Assignee
ERIMOS PHARMACEUTICALS LLC
US·2 granted patents·5 pending applications·10 citations·filing 2005–2022
Top patents by PatentIndex Score
7 records- 0180US7728036B2Methods for delivery of catecholic butanes for treatment of tumorsERIMOS PHARMACEUTICALS LLC·Filed 2005·Granted Jun 1, 2010·10 cites·95 claims
- 0255US11844768B2Terameprocol and nordihydroguaiaretic acid (NDGA) derivatives as coronavirus anti-viral agentsERIMOS PHARMACEUTICALS LLC·Filed 2022·Granted Dec 19, 2023·0 cites·22 claims
- 0345US2009022803A1Oral Formulations For Delivery of Catecholic Butanes Including Ndga CompoundsERIMOS PHARMACEUTICALS LLC·Filed 2006·Application pending·0 cites
- 0445US2008096967A1Formulations for Injection of Catecholic Butanes, Including Ndga Compounds, Into AnimalsERIMOS PHARMACEUTICALS LLC·Filed 2006·Application pending·0 cites
- 0543US2010093872A1Stable aqueous formulations of water insoluble or poorly soluble drugsERIMOS PHARMACEUTICALS LLC·Filed 2009·Application pending·0 cites
- 0643US2006141029A1Methods and compositions for delivery of catecholic butanes for treatment of diseasesERIMOS PHARMACEUTICALS LLC·Filed 2005·Application pending·0 cites
- 0737US2015374709A1Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical useERIMOS PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ERIMOS PHARMACEUTICALS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →